title: Vorapaxar, combination antiplatelet therapy, and stroke.
authors.affiliation: Population Health Research Institute, Hamilton Health Sciences, Department of Medicine (Neurology), McMaster University, Hamilton, Ontario, Canada. Electronic address: robert.hart@phri.ca.
authors.forename: Robert G
authors.initials: RG
authors.lastname: Hart
authors.affiliation: Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai Medical Center, New York, New York.
authors.forename: Jonathan L
authors.initials: JL
authors.lastname: Halperin
authors.affiliation: Thrombosis and Atherosclerosis Research Institute, Hamilton Health Sciences, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
authors.forename: Jeffrey I
authors.initials: JI
authors.lastname: Weitz
mesh_terms: D002545:Brain Ischemia / Q000188:drug therapy* / Q000453:epidemiology*; D003328:Coronary Thrombosis / Q000175:diagnosis* / Q000517:prevention & control*; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D007783:Lactones / Q000008:administration & dosage*; D008297:Male; D011725:Pyridines / Q000008:administration & dosage*; D018179:Receptors, Thrombin / Q000037:antagonists & inhibitors*; D020521:Stroke / Q000188:drug therapy* / Q000453:epidemiology*
chemical_list: D007783:Lactones; D011725:Pyridines; D018179:Receptors, Thrombin; C530299:vorapaxar
keywords: PAR-1 receptor; acute coronary syndrome; antiplatelet; intracerebral hemorrhage; peripheral arterial disease; platelet activation; platelet aggregation inhibitors